skip to Main Content

Congratulations to Peter Sage on Being Awarded an R21 to Study SARS-CoV-2 Vaccine Responses in Aging



The Sage Lab has recently been awarded an R21 grant to study how B cell responses to SARS-CoV-2 vaccines are altered in contexts of preclinical aging.

Back To Top